These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 3358638

  • 1. Early oral contraceptive use as a prognostic factor in breast cancer.
    Olsson H, Möller TR, Ranstam J, Borg A, Fernö M.
    Anticancer Res; 1988; 8(1):29-32. PubMed ID: 3358638
    [Abstract] [Full Text] [Related]

  • 2. Survival in breast cancer and age at start of oral contraceptive usage.
    Ranstam J, Olsson H, Garne JP, Aspegren K, Janzon L.
    Anticancer Res; 1991; 11(6):2043-6. PubMed ID: 1776838
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing.
    Jernström H, Loman N, Johannsson OT, Borg A, Olsson H.
    Eur J Cancer; 2005 Oct; 41(15):2312-20. PubMed ID: 16118051
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. At pill's 30th birthday, breast cancer question is unresolved.
    Althaus FA, Kaeser L.
    Fam Plann Perspect; 1990 Oct; 22(4):173-6. PubMed ID: 2226748
    [Abstract] [Full Text] [Related]

  • 10. A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancer.
    Olsson H, Borg A, Ewers SB, Fernö M, Möller T, Ranstam J.
    Med Oncol Tumor Pharmacother; 1986 Oct; 3(2):77-81. PubMed ID: 3747639
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Researchers can now investigate long-term effects of OCs on cancer.
    Rubin GL, Peterson HB.
    Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
    [Abstract] [Full Text] [Related]

  • 13. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
    Kay CR.
    Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Possible link between long-term oral contraceptive use and cervical cancer].
    Perspect Int Planif Fam; 1987 Dec; (Spec No):40-1. PubMed ID: 12269054
    [Abstract] [Full Text] [Related]

  • 16. Oral contraceptives and survival in breast cancer patients aged 20 to 54 years.
    Trivers KF, Gammon MD, Abrahamson PE, Lund MJ, Flagg EW, Moorman PG, Kaufman JS, Cai J, Porter PL, Brinton LA, Eley JW, Coates RJ.
    Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1822-7. PubMed ID: 17855700
    [Abstract] [Full Text] [Related]

  • 17. Oral contraceptives and breast cancer. A meta-analysis.
    Delgado-Rodriguez M, Sillero-Arenas M, Rodriguez-Contreras R, López Gigosos R, Gàlvez Vargas R.
    Rev Epidemiol Sante Publique; 1991 Sep; 39(2):165-81. PubMed ID: 1830968
    [Abstract] [Full Text] [Related]

  • 18. Risks of oral contraceptive use in women over 35.
    Stenchever MA.
    J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B, Zhang N, Naritoku WY, Tsao-Wei DD, Groshen SL, Carlsson G, Larsson L, Gustavsson B, Chaiwun B, Taylor CR, Imam SA.
    Anticancer Res; 2004 Dec; 24(4):2391-400. PubMed ID: 15330189
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.